Search
  • Aundrea Foster

What is the future of the hemp industry under the Biden administration?


The hemp industry may be off to a bumpy start under the Biden administration. The day after the inauguration, the Food and Drug Administration (FDA) withdrew a proposal to regulate over-the-counter-CBD.


Although media reports indicate that the action was anticipated, it caused yet another frustrating setback to the hemp industry. At a time when consumer interest in hemp products is growing, the industry still lacks clarity on several key legal components that can affect the potential success and liabilities of hemp businesses.


The FDA’s Cannabidiol Enforcement Policy Draft Guidance for Industry was sent to the White House Office of Management and Budget in July 2020. The proposal was submitted over a year after the FDA renewed its efforts to review cannabinoids like CBD, but the details of the proposal were reportedly never made public.


It only needed approval by the White House Office of Management and Budget before it could be made public. However, that never happened under the Trump administration.


The proposal was reportedly withdrawn January 21, after the Biden administration issued a memo instructing all federal agencies to withdraw pending rules.


Regulation of over-the-counter CBD products is widely considered to be overdue. The hemp industry relies on FDA regulations for guidance regarding the types of hemp products they can legally sell, the quality that those products legally must meet, the details that must legally be on the product labels, and the way those products can legally be marketed.


So far, the FDA has only approved one CBD product, Epidiolex, which is a prescription drug used to treat two severe forms of epilepsy.


The FDA does not have a deadline to meet when setting regulations for over-the-counter CBD products, and there has been no mention of an FDA timeline for resubmitting a new CBD proposal. However, an FDA spokesperson reportedly told HEMP Industry Daily that the FDA “will work closely with the new administration to advance appropriate regulations and policies that are in line with the agency’s public health mission.”


Despite the initial setback of this withdrawn proposal, the hemp industry may still be likely to expand under the Biden administration.


“The hemp industry and the farmers who grow the plant have enjoyed strong bipartisan support amongst policymakers in Washington D.C. for the past several years,” according to a Forbes article from last November. “Hemp is one of those policy issues that unites leaders across party and ideological lines.”


The article also predicted that the hemp industry will likely have opportunities to expand under the Biden administration because hemp industry growth compliments other goals that this administration is expected to prioritize.

“[W]e're … likely to see a variety of policies that come out of a Biden Administration that support the increased growth of industrial hemp because the plant fits under the tenets of [Biden’s] vision for economic and global agronomic policy surrounding carbon capture, sustainability, and plant based economies,” the article stated.


Some sources claim that Biden’s nomination for the Assistant Health and Human Services Secretary position is an encouraging start. Dr. Rachel Levine, who Biden chose to fill the position, has reportedly written about medical marijuana throughout her career. The American Trade Association of Cannabis and Hemp even reportedly referred to her as a “trailblazer” in Pennsylvania where she has served as the state’s physician general, assistant health secretary, and state secretary.


Biden’s picks for the Secretary of Health and Human Services position and for the Vice President position could also indicate positive changes for the industry are ahead. Xavier Becerra, who is currently serving as California’s Attorney General, pledged in 2017 to protect the state’s legal cannabis market from actions that could have been taken by the Trump administration. Vice President Kamala Harris was the lead Senate sponsor of the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act.


Although the hemp industry may be off to a bumpy start under the Biden administration, there is still hope for positive change. Ultimately, there is no telling what possibilities lay ahead.


Sources


[1] https://hempindustrydaily.com/fda-withdraws-pending-cbd-enforcement-proposal/

[2] https://hempindustrydaily.com/fda-submits-cbd-enforcement-policy-draft-guidance-to-white-house/

[3] https://www.supermarketnews.com/cbd/fda-clarifies-regulatory-stance-cbd-products

[4] https://www.forbes.com/sites/roberthoban/2020/11/23/dea-bullies-legal-hemp-industry-again/?sh=6bcb77cb6586

[5] https://foodinstitute.com/focus/cbd-market-likely-to-expand-under-biden-administration/

[6] https://www.cnn.com/2021/01/19/politics/rachel-levine-health-and-human-services/index.html

14 views0 comments

 LOCATIONS

SAINT PAUL 

844 Grand Ave Saint Paul MN

55105

Orlando | Dixie Bell

948 S Sermon Blvd 

Orlando Florida 32807

MAPLEWOOD MALL  

 (moved location 3 miles downtown White Bear Lake)

3001 White Bear Ave  Maplewood, MN 55109

©2020 by Nothing But Hemp. Proudly created by SocialThis, LLC

 

Nothing But Hemp offers CBD oil in Minneapolis and the surrounding cities. CBD Oil Products is not for use by or sale to persons under the age of 18. This product should be used only as directed on the label. It should not be used if you are pregnant or nursing. Consult with a physician before use if you have a serious medical condition or use prescription medications. A Doctor's advice should be sought before using this and any supplemental dietary product. All trademarks and copyrights are property of their respective owners and are not affiliated with nor do they endorse this product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. These products contain up to .03% THC. Individual weight loss results will vary. Contact Support for return policy.

The Nothing But Hemp, LLC shall not be held liable for the medical claims made by customer testimonials. The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products and the testimonials made have not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners and legal professionals. Please consult your healthcare professional about potential interactions or other possible complications before using any product. Please consult your own legal counsel to determine whether your purchase and intended use are legal in your state.

 

The Federal Food, Drug, and Cosmetic Act requires this notice.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease or ailment.

 

The Nothing But Hemp, LLC assumes no responsibility for the improper use of these products. We recommend consulting with a qualified medical doctor or physician when preparing a treatment plan for any and all diseases or ailments.

 

The Nothing But Hemp, LLC not make any health claims about our products and recommend consulting with a qualified medical doctor or physician prior to consuming our products or preparing a treatment plan. It is especially important for those who are pregnant, nursing, chronically ill, elderly or under the age of 18 to discuss the use of these products with a physician prior to consuming.  You must be 18 years or older to visit this website and/or purchase Nothing But Hemp, LLC  products. 

 

The information on our website is intended to provide general information regarding our products and is not to be construed as medical advice or instruction.

18K.02 DEFINITIONS.

Subd. 3.Industrial hemp. “Industrial hemp” means the plant Cannabis sativa L. and any part of the plant, whether growing or not, including the plant’s seeds, and all the plant’s derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis. Industrial hemp is not marijuana as defined in section 152.01, subdivision 9.